Headshot of John W. Krakauer.

John W. Krakauer

Professor of neurology
Johns Hopkins University

John Krakauer is professor of neurology and director of the Center for the Study of Motor Learning and Brain Repair at Johns Hopkins University in Baltimore, Maryland. His clinical interest is stroke, including ischemic cerebrovascular disease, subarachnoid and intracerebral hemorrhage, arteriovenous malformation, cerebral vasculitis, cerebral aneurysm, and venous and sinus thrombosis.

He received his B.A. from Cambridge University and his M.D. from Columbia University College of Physicians and Surgeons, where he was elected to Alpha Omega Alpha Medical Honor Society. After completing an internship in internal medicine at the Johns Hopkins Hospital, he returned to Columbia University for his residency in neurology at the Neurological Institute of New York. He subsequently completed a research fellowship in motor control in the Center of Neurobiology and Behavior at Columbia and a clinical fellowship in stroke at the Neurological Institute at Columbia University Medical Center.

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read